Negative Implications of Drug and Substance use on Mental Health

Okoye, Nelyn Akunna *

Department of Health Service, Rivers State University, Nigeria.

Udeji, Rosemary Nneka

Ikate Primary Health Centre, Lagos State, Nigeria.

Ordu, Charles Nkesi

Department of Health Service, Rivers State University, Nigeria.

Aneke, Emeka John

University of Nigerian Teaching Hospital, Enugu State, Nigeria.

Offor, Chinazor Cordelia

St. Catherine’s Specialist Hospital Port Harcourt, Nigeria.

Asanya, Chinyere Ada

U.S Food and Drug Administration, Tampa Florida, USA.

*Author to whom correspondence should be addressed.


Abstract

Mental health refers to a person's emotional, psychological, and social well-being, which encompasses aspects such as thoughts, feelings, behaviors, and the ability to cope with life's challenges. Several factors including drug abuse have been recognized to cause mental health disorders; hence, the urgent need to globally address these factors. Drug abuse emerges as a complex public health issue, involving the misuse of legal and illegal drugs, with consequences extending beyond individual health. The relationship between mental health and drug abuse intensifies challenges, as drug misuse contributes to the development or worsening of mental health disorders. This review examined biological, psychological, and social determinants, and advocate for a standardized approach to address the complex issue of drug abuse. Various electronic databases, such as PubMed, Scopus, Web of Science, Medline, and others, were used to access resources, in which thirty-three (33) literatures were reviewed. Results of the reviewed literatures revealed that the impact of drug abuse on mental health involves neurobiological alterations affecting neurotransmitter levels and structural changes in the brain. This does not only affect individuals, but also results in societal burdens, such as increased healthcare costs and criminal justice involvement, compounded by the stigma surrounding mental health and substance abuse. The classification of drugs into legal and illegal categories highlights the diversity of substances and emphasizes the need to understand their effects on mental well-being. Categories include legal drugs, prescription medications, socially accepted substances, and illegal drugs with varying dependency potentials. Addressing mental health disorders induced by drug abuse requires a comprehensive approach, involving strategies like Integrated Dual Diagnosis Treatment (IDDT), Medication-Assisted Treatment (MAT), Cognitive-Behavioral Therapy (CBT), Motivational Interviewing (MI), Dialectical Behavior Therapy (DBT), Peer Support, 12-Step Programs, and Recovery-Oriented Systems of Care (ROSC). These methods guarantee a care continuum that centers on the individual and emphasizes recovery, acknowledging the relationship between mental health and drug abuse disorders. Nevertheless, the review highlights a research gap in that, in-depth research is needed to evaluate the effectiveness of the aforementioned interventions. Additionally, exploring innovative strategies to address challenges such as stigma, limited treatment accessibility, and the cyclical nature of addiction would enhance intervention effectiveness.

Keywords: Mental health, drug abuse, well-being, global public health, depression, anxiety, bipolar disorder


How to Cite

Akunna, O. N., Nneka, U. R., Nkesi, O. C., John, A. E., Cordelia, O. C., & Ada, A. C. (2024). Negative Implications of Drug and Substance use on Mental Health. International Neuropsychiatric Disease Journal, 21(4), 18–25. https://doi.org/10.9734/indj/2024/v21i4439

Downloads

Download data is not yet available.

References

Sun Y, Wu Y, Fan S, Zhang L, Lin Y, Feng C, Chang J. Comparison of mental health symptoms before and during the COVID-19 pandemic: Evidence from a systematic review and meta-analysis of 134 cohorts. BMJ. 2023;380:e074224. Available:https://doi.org/10.1136/bmj-2022-0742241

Pfefferbaum B, North CS. Mental health and the Covid-19 pandemic. New England Journal of Medicine. 2020;383 (6):510–512. Available:https://doi.org/10.1056/NEJMp2008017

Rajkumar RP. COVID-19 and mental health: A review of the existing literature. Asian Journal of Psychiatry. 2020;52: 102066. Available:https://doi.org/10.1016/j.ajp.2020.102066

World Health Organization. Mental health; 2022. Available:https://www.who.int/news-room/fact-sheets/detail/mental-health-strengthening-our-response

National Institute on Drug Abuse. Commonly abused drugs; 2018. Available:https://nida.nih.gov/sites/default/files/commonly_abused_drugs.pdf

Jones TM, Hill KG, Epstein M, Lee JO, Hawkins JD, Catalano RF. Understanding the interplay of individual and social-developmental factors in the progression of substance use and mental health from childhood to adulthood. Development and Psychopathology. 2016;28(3):721–741.

Lim D, Lee WK, Park H. Disability-adjusted life years (DALYs) for mental and substance use disorders in the korean burden of disease study 2012. Journal of Korean Medical Science. 2016;31(2):191–199.

Gittins R, Missen L, Maidment I. Misuse of medication in adult substance misuse services: A systematic review protocol. British Medical Journal. 2021;11(6):1–6.

Volkow ND, Koob GF, McLellan AT. Neurobiologic advances from the brain disease model of addiction. The New England Journal of Medicine. 2016;37 4(4):363–371.

Volkow ND, McLellan AT. Opioid abuse in chronic pain--misconceptions and mitigation strategies. The New England Journal of Medicine. 2016;374(13):1253–1263.

Magura S, Rosenblum A, Fong C. Factors associated with medication adherence among psychiatric outpatients at substance abuse risk. The Open Addiction Journal. 2011;4(1):58–64.

Volkow ND. Personalizing the treatment of substance use disorders. The American Journal of Psychiatry. 2020;177(2):113–116.

Nestler EJ. Reflections on: A general role for adaptations in G-Proteins and the cyclic AMP system in mediating the chronic actions of morphine and cocaine on neuronal function. Brain Research. 2015; 1628(1):142–145.

Koob GF, Volkow ND. Neurobiology of addiction: A neurocircuitry analysis. The Lancet Psychiatry. 2016;3(8):760–773.

Vigo D, Thornicroft G, Atun R. Estimating the true global burden of mental illness. The Lancet Psychiatry. 2016;3(2):171–178.

Corrigan PW. (Ed.). On the stigma of mental illness: Practical strategies for research and social change. American Psychological Association; 2005.

Barrett EL, Teesson M, Mills KL. Associations between substance use, post-traumatic stress disorder and the perpetration of violence: A longitudinal investigation. Addictive Behaviors. 2014;39 (1):1075–1080.

Longman-Mills S, Abel W, De La Haye W. Substance abuse during adulthood subsequent to the experience of physical abuse and psychological distress during childhood. West Indian Medical Journal. 2015;2(1):7–10.

Volkow ND, Wang GJ, Telang F, Fowler JS, Logan J, Childress AR, Jayne M, Ma Y, Wong C. Cocaine cues and dopamine in dorsal striatum: Mechanism of craving in cocaine addiction. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience. 2006;26(24): 65 83–6588.

Sulzer D, Sonders MS, Poulsen NW, Galli A. Mechanisms of neurotransmitter release by amphetamines: A review. Progress in Neurobiology. 2005;75(6):406–433.

Sieghart W. Allosteric modulation of GABAA receptors via multiple drug-binding sites. Advances in Pharmacology. 2015;72 (1):53–96.

National Institute on Drug Abuse. Commonly Used Drugs Charts; 2020.

Available:https://nida.nih.gov/research-topics/commonly-used-drugs-charts

Substance Abuse and Mental Health Services Administration. Mental Health and Substance Use Disorders; 2018. Available:https://www.samhsa.gov/find-help/disorders

National Institute on Alcohol Abuse and Alcoholism. Alcohol's effects on the body; 2021.

Available:https://www.niaaa.nih.gov/publications/brochures-and-fact-sheets/alcohols-effects-body

National Institute on Drug Abuse. What is marijuana?; 2019.

Available:https://nida.nih.gov/publications/drugfacts/cannabis-marijuana

Drake RE, Mercer-McFadden C, Mueser KT, McHugo GJ, Bond GR. Review of integrated mental health and substance abuse treatment for patients with dual disorders. Schizophrenia Bulletin. 1998;24 (4):589–608.

McGovern MP, Lambert-Harris C, Acquilano S, Xie H, Alterman AI, Weiss RD. Cognitive behavioral therapy for co-occurring substance use and posttraumatic stress disorders. Addictive Behaviors. 2009;34(10):892–8 97.

Miller WR, Rollnick S. Motivational interviewing: Helping people change. Alcohol and Alcoholism. 2013;48 (3):376–377.

Linehan MM. Skills Training manual for treating borderline personality disorder; 1993.

Available:https://books.google.com.ng/books/about/Skills_Training_Manual_for_Treating_Bord.html?id=qyZ0QgAACAAJ&redir_esc=y

Humphreys K. Professional interventions that facilitate 12-step self-help group involvement. Alcohol Research & Health: The Journal of the National Institute on Alcohol Abuse and Alcoholism. 1999;23 (2):93–98.

Substance Abuse and Mental Health Services Administration. Recovery and Recovery Support; 2012.

Available:https://www.samhsa.gov/find-help/recovery

Keyes CL. Promoting and protecting mental health as flourishing: A complementary strategy for improving national mental health. The American Psychologist. 2007;62(2):95–108.

Kessler RC, Chiu WT, Demler O, Merikangas KR, Walters EE. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Archives of General Psychiatry. 2005;62(6):617–627.